ArticleNature communications2025

Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts.

Mario Mietzsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.